In vitro cytokine production of tnfα and IL-13 correlates with acute liver transplant rejection
Human Immunology , Volume 62 - Issue 11 p. 1258- 1265
Individuals may differ in their capacity to produce cytokines. Since cytokines play a key role in allograft rejection, we investigated whether inter-individual differences in cytokine production by in vitro stimulated PBMC are related to the occurrence of acute liver transplant rejection. Our study group comprised 49 liver transplant recipients and 30 healthy individuals. Rejection, which occurred within one month after liver transplantation, was defined in 22 patients ("rejectors") as biopsy-proven rejection, treated with high dose prednisolone. Patients who never experienced rejection episodes were termed as "nonrejectors" (n=27). PBMC of healthy individuals and of liver transplant recipients, collected late after transplantation (mean 3.5 years), were cultured in the presence and absence of Concanavalin A. The production of TNF-α, IFN-, IL-10, and IL-13 was measured in supernatant after 1, 2, 3, 4, and 7 days of cell culture. In cell culture, stimulated PBMC of rejectors were found to produce significantly higher levels of TNF-α, while there was a trend towards higher production of IFN- and IL-10 as compared to nonrejectors. After grouping patients into high or low cytokine producers based upon reference levels of the healthy individuals using multivariate analysis it was found that occurrence of acute liver transplant rejection correlated to high production of TNF-α and low production of IL-13. After stimulated cell culture PBMC of liver transplant recipients show a differential production of TNF-α and IL-13 which is correlated with the occurrence of acute liver transplant rejection.
|Cytokine, Human, IFN-γ, IL-10, IL-13, Liver, Rejection, TNF- α, Transplantation|
|Organisation||Department of Pathology|
Warlé, M.C, Farhan, M, Metselaar, H.J, Hop, W.C.J, van der Plas, A.J, Kap, Y.S, … Bouma, G.J. (2001). In vitro cytokine production of tnfα and IL-13 correlates with acute liver transplant rejection. Human Immunology, 62(11), 1258–1265. doi:10.1016/S0198-8859(01)00321-4